3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
4
Leukemia, Myeloid, Acute
4
Myelodysplastic Syndromes
3
Polycythemia Vera
2
Neoplasms
2
Myeloproliferative Disorders
2
Leukemia
2
Graft vs Host Disease
2
Thrombocythemia, Essential
1
Thalassemia
1
Preleukemia
1
Precancerous Conditions
1
Neoplasms by Histologic Type
1
Myelodysplastic-Myeloproliferative Diseases
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, B-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Glioma
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
Bronchiolitis Obliterans Syndrome
1
Bone Marrow Diseases
1
Interventions
Tamoxifen
5
Specimen Handling
4
exemestane
2
Letrozole
2
Anastrozole
2
fezolinetant
1
elacestrant
1
Testosterone
1
Surgical Procedures, Operative
1
Omacor
1
Neoadjuvant Therapy
1
FAPI-46
1
Biopsy
1
4-hydroxy-N-desmethyltamoxifen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Intraductal, Noninfiltrating
×
ruxolitinib
×
30 days
×
Clear all
No trials found.